DKDaniil Kirianov

Daniil Kirianov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniil Kirianov has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Altered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy

    by Constanza Bravo-Rossainz Baez, Xian Xin, Hang Lyu, Daniil Kirianov, Ying Sun, Erik Späte, Mariapia Grassia, Birgit Engeland, Malte Stockebrand, Konstantin Khodosevich, et al.

    Gain-of-function variants in SCN2A, encoding the voltage-gated sodium channel Na V 1.2, cause developmental and epileptic encephalopathies characterized by seizures, developmental delay, and white matter abnormalities. While Na V 1.2 is known to regulate neuronal excitability, its role in oligodendroglial cells is unclear. Here, we show that Na V 1.2 is expressed in early oligodendrocyte lineage stages. In mice carrying the gain-of-function Scn2a p.A263V variant, oligodendrocyte precursor cells displayed similar Na V 1.2 expression, but altered electrophysiological properties and calcium signaling. Single-cell transcriptomics revealed stage-specific changes in oligodendroglial maturation during early postnatal development, associated with lower variability and slightly faster conduction velocities. In adult mutant mice, gray matter myelination was increased without changes in oligodendrocyte numbers or myelin structure. Since Na V 1.2 was absent from mature oligodendrocytes, the enhanced myelination likely reflects an activity-dependent adaptation to altered neuronal network activity rather than a primary myelinopathy. These findings identify a glial contribution to SCN2A -related disease mechanisms and underscore the need to consider neuron–glia interactions when developing targeted therapies for epilepsy.

  • Open Access

    Early postnatal CA3 hyperexcitability drives hippocampal development and epileptogenesis in SCN2A developmental and epileptic encephalopathy

    by Yana Reva, Katharina Ulrich, Xian Xin, Yuanyuan Liu, Michaela Barboni, Daniil Kirianov, Nima Mojtahedi, Sarah Schoeb, Hanna Oelßner, Daria Savitska, et al.

    Developmental and epileptic encephalopathies caused by pathogenic variants in SCN2A ( SCN2A -DEE), encoding the voltage-gated sodium channel Na v 1.2, present with early-life seizures, developmental delay, and increased mortality. Using a novel Scn2a p.A263V gain-of-function (GOF) mouse model, we demonstrate gene-dose and background-dependent phenotypes ranging from self-limited neonatal seizures to chronic epilepsy with high mortality. In vivo electrophysiology revealed hippocampal seizures as early as postnatal day 2.5, with CA3-driven gamma oscillations preceding seizure onset. CA3 and CA1 pyramidal neurons exhibited transient hyperexcitability during early postnatal development, resolving by P24-30. Single-cell RNA sequencing uncovered gene dose-dependent accelerated maturation of hippocampal networks, peaking at P7, alongside widespread transcriptional changes in excitatory and inhibitory neurons. In adulthood, persistent hippocampal network alterations emerged, marked by reduced mid-gamma oscillations and theta-gamma coupling. Our findings establish hippocampal CA3 hyperexcitability as an early driver of epileptogenesis in SCN2A -DEE and highlight it as a potential therapeutic target to mitigate disease progression.